Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Niveau de preuve du suivi thérapeutique pharmacologique de l'efavirenz.
Solas C, Gagnieu MC; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Solas C, et al. Therapie. 2011 May-Jun;66(3):197-205. doi: 10.2515/therapie/2011033. Therapie. 2011. PMID: 27393199 French.
[Evidence-based therapeutic drug monitoring for nevirapine].
Muret P, Piedoux S, Solas C, Quaranta S; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Muret P, et al. Among authors: solas c. Therapie. 2011 May-Jun;66(3):187-95. doi: 10.2515/therapie/2011030. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819802 Review. French.
[Evidence-based therapeutic drug monitoring for efavirenz].
Solas C, Gagnieu MC; roupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Solas C, et al. Therapie. 2011 May-Jun;66(3):197-205. doi: 10.2515/therapie/2011033. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819803 Review. French.
[Evidence-based therapeutic drug monitoring for saquinavir].
Muret P, Solas C; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Muret P, et al. Among authors: solas c. Therapie. 2011 May-Jun;66(3):207-12. doi: 10.2515/therapie/2011029. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819804 Review. French.
[Evidence-based therapeutic drug monitoring of atazanavir].
Solas C, Muret P; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Solas C, et al. Therapie. 2011 May-Jun;66(3):213-9. doi: 10.2515/therapie/2011032. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819805 Review. French.
[Evidence-based therapeutic drug monitoring for ribavirine].
Solas C, Paré M, Quaranta S, Stanke-Labesque F; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Solas C, et al. Therapie. 2011 May-Jun;66(3):221-30. doi: 10.2515/therapie/2011036. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819806 Review. French.
Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
Lê MP, Solas C, Garraffo R, Gagnieu MC, Muret P, Yeni P, Dhiver C, Katlama C, Poizot-Martin I, Durant J, Peytavin G. Lê MP, et al. Among authors: solas c. J Antimicrob Chemother. 2012 Nov;67(11):2779-81. doi: 10.1093/jac/dks260. Epub 2012 Jul 6. J Antimicrob Chemother. 2012. PMID: 22773742 No abstract available.
145 results